Friday, June 25, 2021

Thyrocare Technologies Ltd (500312) – PharmEasy’s parent API Holdings acquiring is a gamechanger

Thyrocare Technologies Ltd (500312)  closes   at ₹1448.05 with  a  Gain   of   +6.20%   on    25-June-2021  with formation of  a  Long  green Candle    on Daily  Price Chart.

About the Company : Thyrocare is the largest B2B player in the diagnostics space and has a network of over 3,330 collection centres across 2,000 towns in India. It operates a multi-lab model with 1 mega central processing lab, two zonal processing labs and 13 regional processing labs across the country.

Sector Update :  India’s ehealth sector reached about $1.4 billion GMV in 2020 and is expected to grow around 10 times over the period of CY20-25. The industry is expected to grow its GMV by $11-15 billion by CY25.

Financials : Thyrocare Technologies Ltd  has posted Net Sales / Revenue   of ₹494.60 Cr & Net Profit of  ₹113.10 Cr in FY2021 and expected to post Net Sales / Revenue   of ₹564.30Cr & Net Profit of ₹141.90 Cr in FY2022 & Net Sales / Revenue   of ₹635.60 Cr & Net Profit of ₹164.00 Cr in FY2023 and Net Sales / Revenue   of ₹741.30 Cr & Net Profit of ₹183.30 Cr in FY2024.

EPS will be improved from 21.4 in FY2021 to 31.50 in FY2023 & 20.40 in FY2023, Free Cash Flow will increase from ₹88.00 Cr to ₹172.50Cr during the same period. Book Value Per Share will increase from ₹80.80 to ₹92.0 in FY2023 & RoA will increase to 24.6%  by FY2023.

Valuations  : The Company is now Trading at X 4.10  of its  valuations of its FY2021 earnings with ~310% Premium and X3.24 of its FY2022 earnings with ~224% Premium & X2.80 of its FY2023 earnings with ~180%  premium and X2.51of its FY2024 earnings with ~151%  premium.

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.40   which  makes is attractive after ~60% dip in price. The  Equity Value Per Share ( Enterprise Value Method ) is  ₹1445.10

If We factor its FY2024 earnings/valuations, its Price arrives at ₹2368 (without considering PharmEasy).

Market Sentiment   Update : Our Nifty Next Indictor (NNI) is now at 120.04 as on 25-June-2021, which suggests the Return on Equity Investment will be 8.4% in next 6Month; 1.7% in 12M & -5.0% (Negative) in 24M( Based on Historical data).

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Manage your investments the right way With MProfit. Visit https://www.mprofit.in/

Use Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

 

 


No comments:

Post a Comment

Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.

Subscribe to: Post Comments (Atom)

Disclaimer

The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. www.niftynext..com does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.

Blog Archive